Internal Medicine, Infectious Disease · St Louis, MO
NPI
1386881902
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8790 Watson Rd, Suite 201
St Louis, MO, 63119
Phone (314) 543-2800
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
1,000 services
Medicare patients, 2024
310
Average age 74
Drug cost, 2024
$183K
770 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francisco M Pherez was code 99232 (hospital e&m - subsequent), 633 times for 227 patients. In total Francisco M Pherez billed 1,000 services in 9 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 633 | 227 | $58.94 | $37K |
| 99223 Hospital E&M - Initial | Facility | 283 | 246 | $128.84 | $36K |
| 99213 Office E&M - Established | Office | 45 | 30 | $63.17 | $2,843 |
| 99233 Hospital E&M - Subsequent | Facility | 16 | 16 | $90.04 | $1,441 |
| 99231 Hospital E&M - Subsequent | Facility | 14 | 13 | $37.79 | $529 |
By year: 2022 $87K for 1,076 services; 2023 $99K for 1,260 services; 2024 $79K for 1,000 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francisco M Pherez prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 152 prescriptions and refills. In total Francisco M Pherez wrote 770 Medicare prescriptions that cost $183K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 152 | 152 | 34 | $14K |
| Cefazolin Sodium Generic | 70 | 70 | 11 | $4,761 |
| Vancomycin Hcl Generic | 69 | 69 | 21 | $13K |
| Ertapenem Ertapenem Sodium | 52 | 52 | 13 | $21K |
| Doxycycline Hyclate Generic | 45 | 62 | 14 | $2,999 |
| Cephalexin Generic | 40 | 68 | 13 | $1,646 |
| Meropenem Generic | 38 | 38 | Under 11 | $6,338 |
| Cefprozil Generic | 33 | 41 | Under 11 | $2,010 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 28 | 28 | Under 11 | $7,840 |
| Cefdinir Generic | 27 | 29 | Under 11 | $2,404 |
| Daptomycin Generic | 24 | 24 | Under 11 | $41K |
| Cefepime Hcl Generic | 20 | 20 | Under 11 | $4,990 |
| Amoxicillin Generic | 16 | 20 | Under 11 | $101 |
| Rifampin Generic | 16 | 28 | Under 11 | $996 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 16 | 22 | Under 11 | $260 |
Brand drugs: 25 claims; generic drugs: 745 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Francisco M Pherez were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.